General information, events and/or links.




May 19, 2014

Market watch on exosomes!

A growing market interest of exosomes has been detected in some of the largest international financial journals throughout the last years, such as The Wall Street Journal and MarketWatch. Investors have entered the field, and we understand very well that they do!
So far this year, a number of articles covering exosomes have been published in these journals, take a look at some of the articles here:
The Wall Street Journal:

January 13th:
QIAGEN and Exosome Diagnostics to Develop First-In-Class, Non-Invasive Diagnostics for Key Genetic Biomarkers in Lung and Other Cancers 

April 22nd:
Aethlon Medical (AEMD) CEO Note: Cancer Therapy Publication References Aethlon Medical



April 3rd
Exosomes Shine a Light on Alzheimer's Disease and CTE

April 30th:
Are Exosomes the Next PD-1 in Cancer Research?

May 6th:
Capricor Therapeutics Enters Into Exclusive License With Cedars-Sinai Medical Center for Exosome-Related IP Portfolio; Provides Potential for Broad Regenerative Medicine Therapeutic Platform

May 14th:
Exosomes Part and Parcel of Celldex, Pfizer, Incyte and More Cancer Targets

May 15th:
Exosomes Common Link in Cancer Drug Development


And yet, there will be more to come!


Previous page: EVents  Next page: Newsletter